EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microfluidic transfection systems

Rashin Mohammadi, Stavros Stavrakis, Andew J deMello

Advanced Drug Delivery Reviews · 2026

DOI: 10.1016/j.addr.2026.115818 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2026. Verfasst von Rashin Mohammadi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Chemical & Bioengineering, ETH Zürich, 8093 Zürich, Switzerland. Hauptthemen laut MEDLINE: Transfection, Microfluidics. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 221 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ETH Zurich, Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transfection defines the process of introducing foreign biomolecules, such as DNA, RNA, liposomes, nanoparticles, antibodies and antibody fragments, into the cytoplasm or nucleus of a eukaryotic cell, with the aim of engineering or recoding cell function. This process facilitates the study of gene function, the development of personalized-targeted therapies (such as CAR-T cells) and genome editing. Conventional transfection methods are typically based on either carrier-based strategies (leveraging viral and nanoparticle-mediated systems) or the direct membrane disruption methods (such as electroporation and mechanoporation). Whilst useful, such approaches are unable to deliver large amounts of cargo in a manner that is both robust and maintains cellular viability and phenotype. Conversely, microfluidic technologies enable the precise manipulation of fluids, molecules and cells at the microscale level, suggesting potential utility in intracellular delivery. In this review, we examine new transfection technologies, highlighting the emergence of microfluidic platforms as powerful tools in overcoming the aforementioned barriers. This analysis confirms that recent advances in microfluidic electroporation, mechanoporation and sonoporation have enabled improved control over payload delivery, in turn enhancing delivery efficiencies and post-transfection cell viabilities, whilst also supporting scalable and high-throughput operation. We also discuss the roles of analytical detection and process automation in facilitating single-cell studies, high-throughput screening and therapeutic manufacturing. Finally, we highlight remaining challenges associated with clinical translation and provide a perspective on how microfluidic technologies may advance precise, efficient, and clinically relevant intracellular delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TransfectionMicrofluidicsHumansAnimalsElectroporationElectroporation Therapies

Stichwörter der Autor:innen

CRISPRCell therapyDrug deliveryGene editingIntracellular deliveryMicrofluidicsTransfection

Autor:innen und Institutionen

  • Institute for Chemical & Bioengineering, ETH Zürich, 8093 Zürich, Switzerland.
  • Institute for Chemical & Bioengineering, ETH Zürich, 8093 Zürich, Switzerland. Electronic address: andrew.demello@chem.ethz.ch.

Förderung

  • ETH Zurich
  • Swiss National Science Foundation

Zitieren

APA

Mohammadi, R., Stavrakis, S., & deMello, A. J. (2026). Microfluidic transfection systems. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2026.115818

Vancouver

Mohammadi R, Stavrakis S, deMello AJ. Microfluidic transfection systems. Advanced Drug Delivery Reviews. 2026. doi:10.1016/j.addr.2026.115818

BibTeX
@article{Mohammadi2026,
  author = {Mohammadi, Rashin and Stavrakis, Stavros and deMello, Andew J},
  title = {Microfluidic transfection systems},
  journal = {Advanced Drug Delivery Reviews},
  year = {2026},
  doi = {10.1016/j.addr.2026.115818}
}
Kostenlos starten →